肝臓 脳病 の 診断 と 治療 に 対する 実践 的 な アプローチ
Nancy Reau1, David Bernstein2, Paul Kwo3
1Rush University Medical Center, Chicago, IL.
The American journal of medicine
|September 3, 2025
まとめ
肝臓脳病 (HE) の管理には,ガイドラインのよりよい遵守が必要です. この実践的ガイドは,患者,介護者,医療従事者の診断と治療の経路を簡素化し,結果を改善します.
科学分野:
- ヘパトロジー
- 胃腸内科
- 臨床医学
背景:
- 肝臓脳症 (HE) は,不補償性肝硬化症の頻繁な,可逆的な合併症である.
- 繰り返し発生するHEエピソードは 罹病率,死亡率,医療費を大幅に増加させます.
- 既存の高等教育管理ガイドラインの採用と遵守は最適ではない.
研究 の 目的:
- 既存の高等教育診断と管理勧告をより実用的に適用することを提唱する.
- HEスクリーニング,診断,管理のための構造化された臨床ケアパスを提供します.
- 患者,介護者,医療従事者に合わせた 実践的なリソースを提供すること
主な方法:
- 肝臓の病気の専門家の間で多学科のラウンドテーブルディスカッション
- 現在の高等教育のガイドラインと関連するピアレビューされた文献のレビュー
- 臨床ケアに関する出版物の作成 実践的な高等教育管理戦略に焦点を当てた
主要な成果:
- HE診断と管理の実践的なアプローチを提供する包括的な出版物です.
- HEの初期管理,長期維持,予防のための定義された経路
- 患者,介護者,医療従事者向けに ターゲットに絞ったリソースの提供
結論:
- 実践的な HE ガイドラインの遵守が改善されれば,臨床的認識と診断が改善されます.
- 構造化されたケアパスウェイは 効果的な初期管理,維持,予防戦略を容易にする.
- 肝臓脳病の管理における全ての利害関係者への支援には,アクセス可能なリソースが不可欠です.
関連する概念動画
Esophageal Varices-II: Clinical Features and Management
135
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
135
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
Acute Pancreatitis II: Clinical Manifestations and Management
175
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
175
Epilepsy and Seizures: Overview
275
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
275
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666


